Related Experiment Video
Updated: May 22, 2026

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?
Yiqing Zhao1, John Gallon2, Max H Kushner3
1Cancer Biomarker Development, AstraZeneca, Cambridge, United Kingdom.
JCO Precision Oncology
|May 21, 2026
Summary
No abstract available in PubMed .

